Login / Signup

Relation Between Fatigue and ACR Response in Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitor Therapy: A Population-based Cohort Study.

Tanja Schjødt JørgensenMarie SkougaardRebekka Lund HansenChristine BallegaardPhilip MeaseVibeke StrandLene DreyerLars Erik Kristensen
Published in: The Journal of rheumatology (2020)
Fatigue remains a dominating symptom after TNFi treatment, and is associated with higher baseline disease activity, pain, and HAQ scores; more comorbidities; and increased risk of TNFi treatment discontinuation in a cohort of Danish patients with PsA. The agreement between ACR and VAS fatigue responses is weak to moderate, suggesting heterogeneity between experienced fatigue and joint inflammation.
Keyphrases